Overview of methodologic issues for pharmacologic trials in mild, moderate, and severe Alzheimer's disease.
Reisberg B, Franssen EH, Bobinski M, Auer S, Monteiro I, Boksay I, Wegiel J, Shulman E, Steinberg G, Souren LE, Kluger A, Torossian C, Sinaiko E, Wisniewski HM, Ferris SH.
Reisberg B, et al. Among authors: ferris sh.
Int Psychogeriatr. 1996 Summer;8(2):159-93. doi: 10.1017/s1041610296002566.
Int Psychogeriatr. 1996.
PMID: 8994889
Review.